MENU
IGC
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
IGC Pharma (IGC) Ownership - Who owns IGC Pharma?
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer’s disease, period cramps, premenstrual syndrome and chronic pain... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
10224 Falls Road
Phone
+1 301 983-0998
Employees
61
Web
https://www.igcinc.us
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
22.5M
P/E Ratio
N/A
Total Cash
470K
Projected Growth
N/A
Total Debt
270K
Revenue
1.24M
Risk (Beta)
0.47
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
15.73
Revenue/Share
0.02 USD as % of share price
Fundamentals
IGC
Capitalization
22.5M
P/E Ratio
N/A
Risk (Beta)
0.47
Dividend Yield
N/A
Total Cash
470K
Total Cash/Share
0.01
Total Debt
270K
Total Debt/Equity
15.73
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
1.24M
ROE
N/A
Book Value
6.26M
P/B Ratio
3.60
Cash Flow
N/A
Earnings
-0.12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
129M
Current Ratio
1.15
Current Revenue Per Employee
3835.82
Dividends Per Share - Security
N/A
EBITDA
-7.58M
Float
N/A
Float - Current
N/A
Gross Income Margin
40.47
Revenue To Assets
-86.63
Shares Held By Institutions
1.25M
Shares Outstanding - Current
79.7M
Total Liabilities
2.82M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-15.952
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in focuses on developing and commercializing a portfolio of cannabinoid based biopharmaceutical therapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
10224 Falls Road
Phone
+1 301 983-0998
Employees
61
Web
https://www.igcinc.us